MCRB ▼ -2.8% - Seres Therapeutics, Inc.
$MCRB - Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Seres Therapeutics announced inducement grants to certain employees under Nasdaq rules, a routine corporate action that typically has minimal impact on share price. The stock declined 2.8% today, though the headline provides no specific details about grant size, vesting terms, or other factors that might explain the intraday move beyond general market conditions.
08-SEP-2026 06:00 PM ET
Share this post
More filings for $MCRB
View full $MCRB filing history →💬 Comments
Loading comments…
Leave a comment
